- Home
- CTSH vs TAK Comparison
CTSH vs TAK Comparison
Compare CTSH & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSH
- TAK
- Stock Information
- Founded
- CTSH 1994
- TAK 1781
- Country
- CTSH United States
- TAK Japan
- Employees
- CTSH N/A
- TAK N/A
- Industry
- CTSH EDP Services
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- CTSH Technology
- TAK Health Care
- Exchange
- CTSH Nasdaq
- TAK Nasdaq
- Market Cap
- CTSH 38.2B
- TAK 43.9B
- IPO Year
- CTSH 1998
- TAK N/A
- Fundamental
- Price
- CTSH $79.54
- TAK $13.37
- Analyst Decision
- CTSH Hold
- TAK
- Analyst Count
- CTSH 19
- TAK 0
- Target Price
- CTSH $79.94
- TAK N/A
- AVG Volume (30 Days)
- CTSH 4.1M
- TAK 1.8M
- Earning Date
- CTSH 10-30-2024
- TAK 10-31-2024
- Dividend Yield
- CTSH 1.51%
- TAK 4.74%
- EPS Growth
- CTSH 10.28
- TAK 49.73
- EPS
- CTSH 4.52
- TAK 1.27
- Revenue
- CTSH $19,412,000,000.00
- TAK $31,732,209,416.00
- Revenue This Year
- CTSH $4.00
- TAK $4.41
- Revenue Next Year
- CTSH $6.20
- TAK $1.09
- P/E Ratio
- CTSH $17.60
- TAK $20.80
- Revenue Growth
- CTSH N/A
- TAK 9.43
- 52 Week Low
- CTSH $63.79
- TAK $12.58
- 52 Week High
- CTSH $82.41
- TAK $15.08
- Technical
- Relative Strength Index (RSI)
- CTSH 56.27
- TAK 35.93
- Support Level
- CTSH $75.16
- TAK $13.21
- Resistance Level
- CTSH $82.41
- TAK $13.75
- Average True Range (ATR)
- CTSH 1.59
- TAK 0.15
- MACD
- CTSH -0.09
- TAK -0.02
- Stochastic Oscillator
- CTSH 61.68
- TAK 15.53
About CTSH Cognizant Technology Solutions Corporation
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.